支气管动脉灌注化疗联合全身静脉化疗治疗中晚期肺癌的疗效观察

doi:10.3969/j.issn.1002-3070.2010.01.011

实用肿瘤学杂志 ›› 2010, Vol. 24 ›› Issue (1): 45-47.doi: 10.3969/j.issn.1002-3070.2010.01.011

支气管动脉灌注化疗联合全身静脉化疗治疗中晚期肺癌的疗效观察

张瑞珍, 江涛

重庆医科大学附属第一医院呼吸科(重庆 400016)

收稿日期:2010-01-05 出版日期:2010-02-28 发布日期:2015-01-23
作者简介:张瑞珍,女,(1982-),硕士研究生,从事晚期肺癌的介入治疗

Curative effect of chemotherapy on advanced non-small cell lung cancer by bronchial artery infusion plus systemic chemotherapy

ZHANG Ruizhen, JIANG Tao.

Department of Respiratory Medicine.The First Affiliated Hospital of Chongqing Medical University,Chongqing 400016

Received:2010-01-05 Online:2010-02-28 Published:2015-01-23

摘要/Abstract

摘要： 目的研究支气管动脉灌注化疗联合全身化疗治疗中晚期非小细胞肺癌的临床价值。方法 138例中晚期肺癌患者分为两组:A组:介入化疗的同时联合全身静脉化疗;B组:单纯全身静脉化疗。两组全身化疗方案相同。对其临床资料进行回顾性分析。结果 A组近期有效率、半年生存率、年生存率和疾病进展时间分别为61.42%、94.29%、72.86%和85.94天,B组分别为46.27%、82.35%、42.65%和125.23天。两组均有显著性差异。结论中晚期非小细胞肺癌行介入治疗联合全身化疗可明显提高疗效,延长生存期并改善生存质量。

关键词: 中晚期肺癌, 介入治疗, 化疗

Abstract: Objective To study the clinical effect of bronchial artery infusion(BAI)chemotherapy combined with systemic chemotherapy for patient with advanced non-small cell lung cancer.Methods 138 cases with advanced non-small cell lung cancer were divided into two groups.70 cases(A group)received BAI chemotherapy conbimed with systemic chemotherapy.68 cases(B group)were treated with systemic chemotherapy alone.The same systemic chemotherapy was taken in the two groups.The clinical data were analyzed retrospectively.Results Short-term response rate(61.42%),time to progression(TTP)(125.23 days),half-year survival rate(94.29%)and 1-year survival rate(94.29%)in BAI chemotherapy group were significantly higher than those in control group(46.27%,85.94 days,82.35%,42.65% respectively).Conclusion BAI chemotherapy combined with systemic chemotherapy is helpful for patient with advanced non-small cell lung cancer to improve therapeutic effect,to prolong survival time and improve quality of life.

Key words: Advanced lung cancer, Interventional therapy, Chemotherapy

中图分类号:

R734.1

张瑞珍, 江涛. 支气管动脉灌注化疗联合全身静脉化疗治疗中晚期肺癌的疗效观察[J]. 实用肿瘤学杂志, 2010, 24(1): 45-47.

ZHANG Ruizhen, JIANG Tao.. Curative effect of chemotherapy on advanced non-small cell lung cancer by bronchial artery infusion plus systemic chemotherapy[J]. PRACTICAL ONCOLOGY JOURNAL, 2010, 24(1): 45-47.

[1]	冯越,邢丽楠,王棹,张云艳. NLR与肿瘤同步放化疗预后的相关性研究[J]. 实用肿瘤学杂志, 2019, 33(3): 284-288.
[2]	梁虹, 李奇, 王耀先, 靳红, 王铜, 王亚楠, 段雅妮, 宋敏. 宫颈癌化疗心血管毒性预防的间断时间序列试验[J]. 实用肿瘤学杂志, 2019, 33(2): 134-138.
[3]	马志杰, 王帆, 赵亚双. 乳腺癌化疗患者生存质量及影响因素分析[J]. 实用肿瘤学杂志, 2019, 33(2): 149-154.
[4]	秦岚群, 邹征云. 恶性黑色素瘤化疗研究进展[J]. 实用肿瘤学杂志, 2019, 33(2): 167-172.
[5]	常晓霞综述, 宋冰冰, 刘家仁审校. 植物化学物增加肿瘤细胞对化疗药物敏感性的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 67-72.
[6]	姜亮亮综述, 王晶审校. 上皮性卵巢癌远处转移的诊治进展[J]. 实用肿瘤学杂志, 2018, 32(5): 480-482.
[7]	张婷, 贾迪(综述), 杨丹(审校). 骨肉瘤的生物学治疗进展[J]. 实用肿瘤学杂志, 2018, 32(3): 254-257.
[8]	翟可可, 高媛媛, 冯晓, 许静文, 宫玉芳, 孟庆威. 术后辅助化疗后复发转移与初次诊断的IV期NSCLC一线化疗疗效分析[J]. 实用肿瘤学杂志, 2018, 32(2): 107-111.
[9]	杨文娟, 余静, 黄朝, 张俊红, 谢丛华. 化疗早期重度粒细胞下降与小细胞肺癌预后相关性分析[J]. 实用肿瘤学杂志, 2018, 32(1): 19-24.
[10]	黎玉娇, 尚乃舰. 影像学评估乳腺癌新辅助化疗反应的研究进展[J]. 实用肿瘤学杂志, 2018, 32(1): 63-67.
[11]	梁语丝, 谭永刚, 邹华伟审校. 低剂量化疗作用机制的研究进展[J]. 实用肿瘤学杂志, 2017, 31(6): 538-542.
[12]	石峰,于雁. 节拍化疗通过影响血管形成及免疫系统抑制肿瘤细胞生长的机制[J]. 实用肿瘤学杂志, 2017, 31(4): 316-320.
[13]	董峰, 马君俊, 蔡正昊, 赵轩, 郑民华. 血清miR-21和miR-34a与晚期胃癌患者Folfox化疗方案化疗疗效的关系研究[J]. 实用肿瘤学杂志, 2017, 31(2): 147-151.
[14]	陈力, 张玉新, 左艳娇, 马菲, 宋洪江, 薛英威. SOX和XELOX在进展期胃癌新辅助化疗中的临床疗效比较[J]. 实用肿瘤学杂志, 2017, 31(1): 23-30.
[15]	张锐，王智煜，王帅，赵晖. 重组人血管内皮抑素联合NP方案治疗初诊晚期非小细胞肺癌骨转移疗效及对血清VEGF表达的影响[J]. 实用肿瘤学杂志, 2016, 30(6): 527-522.

支气管动脉灌注化疗联合全身静脉化疗治疗中晚期肺癌的疗效观察

Curative effect of chemotherapy on advanced non-small cell lung cancer by bronchial artery infusion plus systemic chemotherapy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价